Bristol Myers Squibb today announced Week 52 data from the pivotal Phase 3 POETYK PsA-1 trial further confirming the efficacy and safety of Sotyktu (deucravacitinib) in adults with active psoriatic ...
While most solar cells on the market today are based on silicon, energy engineers have recently been assessing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback